Your browser doesn't support javascript.
loading
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease.
Bushnell, Justin; Hammers, Dustin B; Aisen, Paul; Dage, Jeffrey L; Eloyan, Ani; Foroud, Tatiana; Grinberg, Lea T; Iaccarino, Leonardo; Jack, Clifford R; Kirby, Kala; Kramer, Joel; Koeppe, Robert; Kukull, Walter A; La Joie, Renaud; Mundada, Nidhi S; Murray, Melissa E; Nudelman, Kelly; Rumbaugh, Malia; Soleimani-Meigooni, David N; Toga, Arthur; Touroutoglou, Alexandra; Vemuri, Prashanthi; Atri, Alireza; Day, Gregory S; Duara, Ranjan; Graff-Radford, Neill R; Honig, Lawrence S; Jones, David T; Masdeu, Joseph; Mendez, Mario; Musiek, Erik; Onyike, Chiadi U; Riddle, Meghan; Rogalski, Emily; Salloway, Steven; Sha, Sharon; Turner, Raymond S; Wingo, Thomas S; Wolk, David A; Carrillo, Maria C; Dickerson, Bradford C; Rabinovici, Gil D; Apostolova, Liana G; Clark, David G.
Afiliación
  • Bushnell J; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Hammers DB; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Aisen P; Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.
  • Dage JL; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Eloyan A; Department of Biostatistics, Center for Statistical Sciences, Brown University, Providence, Rhode Island, USA.
  • Foroud T; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Grinberg LT; Department of Pathology, University of California - San Francisco, San Francisco, California, USA.
  • Iaccarino L; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Jack CR; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Kirby K; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kramer J; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Koeppe R; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Kukull WA; Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
  • La Joie R; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Mundada NS; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Murray ME; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Nudelman K; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Rumbaugh M; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Soleimani-Meigooni DN; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Toga A; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
  • Touroutoglou A; Laboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, Los Angeles, California, USA.
  • Vemuri P; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Atri A; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Day GS; Banner Sun Health Research Institute, Sun City, Arizona, USA.
  • Duara R; Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
  • Graff-Radford NR; Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami, Florida, USA.
  • Honig LS; Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
  • Jones DT; Taub Institute and Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA.
  • Masdeu J; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Mendez M; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Musiek E; Nantz National Alzheimer Center, Houston Methodist and Weill Cornell Medicine, Houston, Texas, USA.
  • Onyike CU; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Riddle M; Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Rogalski E; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Salloway S; Department of Neurology, Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Sha S; Department of Psychiatry and Behavioral Sciences, Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Turner RS; Department of Neurology, Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Wingo TS; Department of Neurology & Neurological Sciences, Stanford University, Palo Alto, California, USA.
  • Wolk DA; Department of Neurology, Georgetown University, Washington D.C., USA.
  • Carrillo MC; Department of Neurology and Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Dickerson BC; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Rabinovici GD; Medical & Scientific Relations Division, Alzheimer's Association, Chicago, Illinois, USA.
  • Apostolova LG; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Clark DG; Department of Neurology, University of California - San Francisco, San Francisco, California, USA.
Alzheimers Dement ; 19 Suppl 9: S29-S41, 2023 11.
Article en En | MEDLINE | ID: mdl-37653686
INTRODUCTION: The Rey Auditory Verbal Learning Test (RAVLT) is a useful neuropsychological test for describing episodic memory impairment in dementia. However, there is limited research on its utility in early-onset Alzheimer's disease (EOAD). We assess the influence of amyloid and diagnostic syndrome on several memory scores in EOAD. METHODS: We transcribed RAVLT recordings from 303 subjects in the Longitudinal Early-Onset Alzheimer's Disease Study. Subjects were grouped by amyloid status and syndrome. Primacy, recency, J-curve, duration, stopping time, and speed score were calculated and entered into linear mixed effects models as dependent variables. RESULTS: Compared with amyloid negative subjects, positive subjects exhibited effects on raw score, primacy, recency, and stopping time. Inter-syndromic differences were noted with raw score, primacy, recency, J-curve, and stopping time. DISCUSSION: RAVLT measures are sensitive to the effects of amyloid and syndrome in EOAD. Future work is needed to quantify the predictive value of these scores. HIGHLIGHTS: RAVLT patterns characterize various presentations of EOAD and EOnonAD Amyloid impacts raw score, primacy, recency, and stopping time Timing-based scores add value over traditional count-based scores.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Memoria Episódica Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Memoria Episódica Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...